Caribou Biosciences, Inc. (CRBU)
1.62
+0.07
(+4.52%)
USD |
NASDAQ |
Feb 18, 16:00
1.62
0.00 (0.00%)
After-Hours: 17:30
Caribou Biosciences Profit Margin (Quarterly) : -1.25K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -- |
| GT Biopharma, Inc. | -- |
| Aclaris Therapeutics, Inc. | -443.0% |
| Nurix Therapeutics, Inc. | -576.1% |
| Lyell Immunopharma, Inc. | -259.0K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -74.16% |
| Return on Assets | -57.99% |
| Return on Invested Capital | -66.02% |
| Gross Profit Margin (Quarterly) | 71.29% |
| Operating Margin (Quarterly) | -1.34K% |
| Return on Net Operating Assets | -415.9% |